Discovery and Development of Cyclic Peptide Inhibitors of CIB1-Reference-Cited by-同舟云学术

Discovery and Development of Cyclic Peptide Inhibitors of CIB1

Published:2021-10-27 Issue:11 Volume:12 Page:1832-1839
ISSN:1948-5875
Container-title:ACS Medicinal Chemistry Letters
language:en
Short-container-title:ACS Med. Chem. Lett.

Author:

Haberman Victoria A.¹²,Fleming Steven R.¹²,Leisner Tina M.²³,Puhl Ana C.²^ORCID,Feng Emerald³,Xie Ling³,Chen Xian³⁴,Goto Yuki⁵⁶^ORCID,Suga Hiroaki⁵⁷^ORCID,Parise Leslie V.³⁴,Kireev Dmitri²^ORCID,Pearce Kenneth H.²⁴,Bowers Albert A.¹²⁴^ORCID

Affiliation:

1. Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, United States

2. Center for Integrative Chemical Biology and Drug Discovery, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, United States

3. Department of Biochemistry and Biophysics, University of North Carolina, Chapel Hill, North Carolina 27599, United States

4. Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina 27599, United States

5. Department of Chemistry, Graduate School of Science, The University of Tokyo, Tokyo 113-0033, Japan

6. JST, PRESTO, Tokyo 113-0033, Japan

7. JST, CREST, Tokyo 113-0033, Japan

Funder

National Institute of General Medical Sciences

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Drug Discovery,Biochemistry

Link